1. "2019"
Formats
  1. Journal Article (2144)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5611)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of locally advanced or metastatic urothelial carcinoma: Analysis of expert and community healthcare provider practice trends
    Meeting Abstract

    Rosenthal, K.; Galsky, M. D.; Milowsky, M. I.; Petrylak, D. P.; Rosenberg, J. E.; Obholz, K.; Plimack, E. R.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Assessment of circulating tumor cell number as a transitional surrogate endpoint for survival in phase II trials for metastatic castration-resistant prostate cancer
    Meeting Abstract

    Scher, H. I.; McCormack, R. T.; Molina, A.; Smith, M. R.; Dreicer, R.; Saad, F.; De Wit, R.; Fizazi, K.; Aftab, D. T.; Limon, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Morphology-predicted, large-scale transition (LST) number in circulating tumor cells (CTC) as a biomarker of chromosomal instability (CIN) to assess early resistance to standard of care (SOC) drugs in mCRPC
    Meeting Abstract

    Scher, H. I.; Schonhoft, J.; Hullings, M.; Carbone, E.; Barnett, E.; Sutton, R.; Jendrisak, A.; Landers, M. A.; Wang, Y.; Dittamore, R.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Mechanisms underlying the association between sarcopenia and poor oncologic outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Sanchez, A.; Kuo, F.; Petruzella, S.; Akin, O.; Paris, M.; Russo, P.; Chan, T. A. T.; Mourtzakis, M.; Hakimi, A. A.; Furber, H.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
    Meeting Abstract

    Shah, A. Y.; Kotecha, R.; Lemke, E.; Chandramohan, A.; Chaim, J.; Msaouel, P.; Xiao, L.; Gao, J.; Campbell, M. T.; Zurita, A. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • External beam radiation therapy and brachytherapy boost versus radical prostatectomy and adjuvant radiation therapy for high-risk prostate cancer
    Meeting Abstract

    Muralidhar, V.; Mahal, B. A. V.; Yang, D. D.; Leeman, J. E.; D'Amico, A. V.; Nguyen, P. L.; Orio, P. F.; King, M. T.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Contemporary analysis of ureteroenteric strictures after open and robot-assisted radical cystectomy: A population-based study
    Meeting Abstract

    Patel, N.; Alshak, M.; Goh, A.; Sedrakyan, A.; Belarmino, A.; Sun, T.; Bochner, B. H.; Hu, J. C.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • EV-301: Phase Ill study to evaluate enfortumab vedotin (EV) versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (Ia/mUC)
    Meeting Abstract

    Petrylak, D. P.; Rosenberg, J. E.; Duran, I.; Loriot, Y.; Sonpavde, G.; Wu, C.; Gartner, E. M.; Melhem-Bertrandt, A.; Powles, T.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Angiogenic and immunomodulatory biomarkers in axitinib-treated patients (pts) with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Rini, B. I.; Escudier, B.; Murphy, D.; Wang, P.; Tarazi, J. C.; Motzer, R. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Time to PSA nadir and the risk of death from prostate cancer following radiation and androgen deprivation therapy
    Meeting Abstract

    Pike, L. R. G.; Wu, J.; Chen, M. H.; Loffredo, M.; Renshaw, A. A.; Pfail, J.; Kantoff, P. W.; D'Amico, A. V.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save